Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2015 1
2016 2
2017 1
2018 4
2019 3
2020 3
2021 11
2022 8
2023 10
2024 14
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
WITHDRAWN: ¿Qué estrategias empleamos en la prevención y el seguimiento del virus del papiloma humano en pacientes con enfermedad inflamatoria intestinal?
Fraga-Blanco P, Boullon-Batalla N, Manuel Benitez J, Suarez-Ferrer C, Baston-Rey I, Calafat M; Grupo Joven de GETECCU. Fraga-Blanco P, et al. Among authors: suarez ferrer c. Gastroenterol Hepatol. 2024 May 17:S0210-5705(24)00169-9. doi: 10.1016/j.gastrohep.2024.502211. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38750953 Retracted. English, Spanish. No abstract available.
Intestinal disease secondary to tocilizumab.
Siljeström Berenguer C, Bonilla G, Suárez-Ferrer C. Siljeström Berenguer C, et al. Among authors: suarez ferrer c. Rev Esp Enferm Dig. 2022 Dec;114(12):755-756. doi: 10.17235/reed.2022.8818/2022. Rev Esp Enferm Dig. 2022. PMID: 35656897 Free article.
Endoscopic imaging of pneumatosis intestinalis.
Siljeström Berenguer C, Pérez Enciso I, Suárez-Ferrer C. Siljeström Berenguer C, et al. Among authors: suarez ferrer c. Rev Esp Enferm Dig. 2022 Nov;114(11):696-697. doi: 10.17235/reed.2022.8972/2022. Rev Esp Enferm Dig. 2022. PMID: 35770544 Free article.
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort.
Suárez Ferrer C, Mesonero Gismero F, Caballol B, Ballester MP, Bastón Rey I, Castaño García A, Miranda Bautista J, Saiz Chumillas R, Benitez JM, Sanchez-Delgado L, López-García A, Rubin de Celix C, Alonso Abreu I, Melcarne L, Plaza Santos R, Marques-Camí M, Caballero Mateos A, Gómez Díez C, Calafat M, Galan HA, Vega Vilaamil P, Castro Senosiain B, Guerro Moya A, Rodriguez Diaz CY, Spicakova K, Manceñido Marcos N, Molina G, de Castro Parga L, Rodriguez Angulo A, Cuevas Del Campo L, Rodriguez Grau MDC, Ramirez F, Gomez Pastrana B, Gonzalez Partida I, Botella Mateu B, Peña Gonzalez E, Iyo E, Elosua Gonzalez A, Sainz Arnau E, Hernandez Villalba L, Perez Galindo P, Torrealba Medina L, Monsalve Alonso S, Olmos Perez JA, Dueñas Sadornil C, Garcia Ramirez L, Martín-Arranz MD, López Sanroman A, Fernández A, Merino Murgui V, Calviño Suárez C, Flórez-Diez P, Lobato Matilla ME, Sicilia B, Soto Escribano P, Maroto Martin C, Mañosa M, Barreiro-De Acosta M; On belhaf of Young group of GETECCU. Suárez Ferrer C, et al. Gastroenterol Hepatol. 2024 Dec;47(10):502197. doi: 10.1016/j.gastrohep.2024.502197. Epub 2024 May 6. Gastroenterol Hepatol. 2024. PMID: 38710465 English, Spanish.
Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU.
Fuentes-Valenzuela E, Bastón-Rey I, García-Alonso FJ, Elosua A, Zabalza San Martín L, Leo Carnerero E, Garcia de la Filia I, Pedraza Pérez A, Sáiz Chumillas RM, Pascual Oliver A, Muñoz Villafranca C, Moreno V, Suárez Ferrer C, Molina G, Ferreiro-Iglesias R, Vega Villaamil P, Gardeazábal Mateos D, Segarra-Ortega JX, Garrido Marín A, Doallo AI, Alonso-Galán H, Brunet-Mas E, Jimenez García N, López Romero-Salazar F, Velayos B, Carballo-Folgoso L, Pérez Santamaría C, Mata Román L, Núñez Ortiz A, Barrio J, Barreiro-de Acosta M, Gutiérrez-Casbas A. Fuentes-Valenzuela E, et al. Among authors: suarez ferrer c. J Crohns Colitis. 2025 May 8;19(5):jjaf058. doi: 10.1093/ecco-jcc/jjaf058. J Crohns Colitis. 2025. PMID: 40205922
Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease.
Martin-Arranz MD, García-Ramírez L, Hernandez-Perez M, Montero Vega D, Martín-Arranz E, Sánchez-Azofra M, Poza Cordon J, Rueda Garcia JL, Noci Belda J, Verges Martínez-Meco T, Blanco San Miguel P, Suarez Ferrer C. Martin-Arranz MD, et al. Among authors: suarez ferrer c. Sci Rep. 2023 Apr 29;13(1):7044. doi: 10.1038/s41598-023-33402-w. Sci Rep. 2023. PMID: 37120662 Free PMC article.
Intensification with Intravenous Ustekinumab in Refractory Crohn's Disease.
Suárez Ferrer C, Arroyo Argüelles J, Rueda García JL, García Ramírez L, Martin Arranz E, Sánchez Azofra M, Poza Cordón J, Noci Belda J, Martin-Arranz MD. Suárez Ferrer C, et al. J Clin Med. 2024 Jan 24;13(3):669. doi: 10.3390/jcm13030669. J Clin Med. 2024. PMID: 38337361 Free PMC article.
53 results